Pular para o conteúdo principal
Ranking Invest

CRNX - Crinetics Pharmaceuticals, Inc.

Segmento: HealthcareCrinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III clinical trial for the treatment of acromegaly, as well as completed phase II clinical trial to treat carcinoid syndrome and nonfunctional neuroendocrine tumors (NETs). The company is also developing CRN04777, an oral selective nonpeptide somatostatin type 5 receptor agonist, which is in phase I clinical trial for the treatment of congenital hyperinsulinism; and CRN04894, an oral adrenocorticotrophic hormone antagonist that is in phase I clinical trial for the treatment of Cushing's and congenital adrenal hyperplasia diseases. Crinetics Pharmaceuticals, Inc. was incorporated in 2008 and is headquartered in San Diego, California.

Análise Ranking Invest

Valor de Mercado
$ 9.01 Bi
IVR
-0.00Índice proprietário de comparação relativa: -0,00.
IVR2
-0.14Leitura proprietária complementar: -14%.
MLL
-0.14Leitura proprietária complementar: -14%.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia proprietária baseada em dados financeiros públicos; fórmulas e valores intermediários são confidenciais.

Dados da Empresa

Patrimônio Líquido

$ 1.19 Bi

Dívida Líquida

-$ 55.50 Mi

L4T

-$ 501.61 Mi

MM4T

-23659.58%

Indicadores Básicos

ROE

-42.08%

Índices de Previsibilidade

Receita Líquida

G21.79

Lucro

A0.08

Margem

D0.91

Índices de Tendência

Receita Líquida

C6.28

Lucro

G-11.52

Margem

D1.03

Índices de Endividamento

DIV/PAT

-0.05

DIV/L4T

0.11

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.